Scientist uncovers switch controlling protein production

Dec 22, 2010

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

The study is published in the December 24, 2010 edition of the .

The study identified the , essentially formed by a small sequence of RNA, that controls a critical part of ribosome synthesis to allow for strict, albeit temporary, regulation of the process.

"These kinds of switches in RNA are thought to be slow acting," said Katrin Karbstein, an assistant professor in the Department of Cancer Biology at Scripps Florida who helped lead the study. "That suggests a point where we might intervene to modify the process – then you could potentially shut down the pathway, because if you don't produce , you cannot make proteins. Thus, cells can't grow. That would be a desirable outcome in cancer, for example."

This slowness may be there precisely so these regulatory points can be introduced for cells to downregulate growth when nutrition is scarce.

"Perhaps, nature has found a way to exploit RNA's Achilles' heel – its propensity to form alternative structures that can lead to misfolding, which, in turn, can cause diseases ranging from Alzheimer's to diabetes," Karbstein said. "Nature might be using this to stall important biological processes and allow for quality control and regulation."

The synthesis of proteins involves ribosomes, large macromolecular machines required for cell growth in all organisms. Ribosomes read the genetic code carried by messenger RNA and then catalyze or translate that RNA code into proteins within cells, assembling them from amino acids.

To produce mature ribosomal RNAs (rRNAs), the catalysts that control protein synthesis in all cells, the body first needs perfectly formed intermediate or pre rRNAs, which can be further processed into fully functioning ones. The intermediate form is produced as an RNA transcript that is cleaved or cut in multiple steps to produce mature rRNA.

"While we believe that this switch is essential for ribosome assembly, it seems unlikely that this is the only event that regulates cleavage," Karbstein said. "However, tight regulation of ribosome is essential to ensure the structural integrity of mature ribosomes."

Cutting Extra Material

The ribosomal RNA that is transcribed has extra material in it, Karbstein said, so it is necessary to cut it down – that's why these cuts or cleavages are so essential to the process of producing the final rRNA product.

The study also suggests RNA itself exploits its own natural ability to form these stable structural switches to order and regulate various RNA-dependent biological processes.

"What is interesting," Karbstein said, "is that as the organism becomes more complex, the number of cleavages needed increases. This may make the process more accurate and that may be an evolutionary advantage, but even in bacteria this cutting is not done in a simple way. We still don't know exactly why that is."

Perhaps these strictly ordered cleavage steps are introduced to produce singularly perfect intermediates, she added. This is important because cleavage is an irreversible energy-releasing process with the potential to shift the landscape of assembly towards the final product. As a result, cleavage steps should be carefully controlled and should only occur if the assembly intermediate is correct.

"Ribosomes make mistakes rarely, on the order of one in 10,000 amino acid changes," Karbstein said. "A lot of this accuracy depends on conversations between different parts of the ribosomes, so if the structure of the isn't correct, these conversations can't happen. And that means more mistakes, and that's not good because it can lead to any number of disease states."

For now, Karbstein said she's interested in looking at small molecules that perturb the switch, and finding out if this affects the quality of the ribosomes produced.

"Certain kinds of antibiotics work by making the ribosomes produce more mistakes – it's not a huge increase but it's enough to make these die," she said. "Maybe we can find molecules that similarly lead to the production of 'worse' ribosomes."

Explore further: Mycologist promotes agarikon as a possibility to counter growing antibiotic resistance

More information: In addition to Karbstein, Allison C. Lamanna is an author of the study, "An RNA Conformational Switch Regulates Pre-18S rRNA Cleavage" doi:10.1016/j.jmb.2010.09.064

Related Stories

Danish researches solve virus puzzle

Mar 30, 2007

How is virus as for example HIV and bird flu able to make the cells within a human body work for the purpose of the virus? Researchers at the University of Copenhagen shed new light on this question.

Nature's quality control in yeast

Aug 30, 2010

(PhysOrg.com) -- Scientists know that in yeast cells, as in other cells, it’s the job of ribosomes to make proteins out of amino acids using information coded in the messenger RNA (mRNA).

Biologists probe the machinery of cellular protein factories

Sep 13, 2006

Proteins of all sizes and shapes do most of the work in living cells, and the DNA sequences in genes spell out the instructions for making those proteins. The crucial job of reading the genetic instructions and synthesizing ...

Bacteria are models of efficiency

Feb 04, 2009

The bacterium Escherichia coli, one of the best-studied single-celled organisms around, is a master of industrial efficiency. This bacterium can be thought of as a factory with just one product: itself. It exists to make c ...

Recommended for you

YEATS protein potential therapeutic target for cancer

Oct 23, 2014

Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not.

Precise and programmable biological circuits

Oct 23, 2014

A team led by ETH professor Yaakov Benenson has developed several new components for biological circuits. These components are key building blocks for constructing precisely functioning and programmable bio-computers.

User comments : 0